Manchester Intermittent versus Daily Diet App Study (MIDDAS): A pilot randomized controlled trial in patients with type 2 diabetes.
Sarah McDiarmidMichelle N HarvieRhona JohnsonAvni VyasAzza AglanJacqui MoranHelen RuaneAmanda HulmeKatharine SellersBasil George IssaPublished in: Diabetes, obesity & metabolism (2021)
The study shows the feasibility and potential efficacy of remotely delivered ILED and CLED programmes for weight loss and HbA1c reduction, and the feasibility of a randomized controlled trial comparing the two approaches.